| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.18M | 120.39M | 152.84M | 159.13M | 152.41M | 114.95M |
| Gross Profit | 81.00M | 80.44M | 107.14M | 113.25M | 109.31M | 59.89M |
| EBITDA | -5.63M | -13.29M | -13.07M | 30.93M | 36.83M | 21.97M |
| Net Income | -21.91M | -30.38M | -33.51M | 13.24M | 19.98M | 4.77M |
Balance Sheet | ||||||
| Total Assets | 83.42M | 86.69M | 117.72M | 159.25M | 133.76M | 119.88M |
| Cash, Cash Equivalents and Short-Term Investments | 7.20M | 8.20M | 7.14M | 6.87M | 25.67M | 11.82M |
| Total Debt | 68.17M | 64.71M | 81.21M | 84.16M | 68.65M | 78.55M |
| Total Liabilities | 100.94M | 97.47M | 106.84M | 112.48M | 96.01M | 101.18M |
| Stockholders Equity | -9.22M | -2.60M | 17.41M | 53.21M | 42.21M | 22.27M |
Cash Flow | ||||||
| Free Cash Flow | -9.82M | 5.13M | -9.65M | -10.21M | 13.90M | 12.45M |
| Operating Cash Flow | -9.31M | 8.10M | 133.00K | 834.00K | 19.21M | 16.57M |
| Investing Cash Flow | -1.26M | -2.86M | -10.02M | -14.17M | 8.08M | -4.10M |
| Financing Cash Flow | 9.09M | -4.10M | 10.35M | -5.70M | -13.43M | -8.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.32B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
64 Neutral | £620.65M | -23.98 | 4.40% | 3.36% | -2.59% | -46.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £3.91B | -40.23 | -2.99% | ― | -9.44% | -170.53% | |
52 Neutral | £68.41M | -2.45 | 370.62% | ― | -15.13% | 48.56% | |
52 Neutral | £259.19M | -1.12 | -111.93% | ― | -14.89% | 12.08% | |
41 Neutral | £260.43M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |